Gary Gilleskie, Ph.D.
Since joining BTEC in 2007, Gary Gilleskie has served in a number of positions, including director of operations from 2012–2017, and is now BTEC’s executive director.
Dr. Gilleskie’s work focuses on the area of downstream processing of biopharmaceuticals, including protein therapeutics, vaccines, and gene therapies. While at BTEC, he has developed and taught numerous courses focused on downstream bioprocessing for audiences ranging from NC State students to industry professionals to the U.S. Food and Drug Administration. He also started BTEC’s bioprocess services program and has collaborated with a number of external organizations on developing processes and new bioprocessing technologies.
Recently, Dr. Gilleskie has led several projects in collaboration with the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in the areas of gene therapy vector manufacturing and single-use processing. These projects have greatly enhanced BTEC’s ability to provide educational opportunities and to collaborate on projects with industry in these areas. He is also a co-PI on a grant from the Novo Nordisk Foundation to start a new program known as Accelerated Innovation in Manufacturing Biologics (AIM-Bio). That grant provides $27 million in funding and will greatly boost BTEC’s professional development offerings and research capabilities.
Prior to joining BTEC, Dr. Gilleskie spent 15 years in both the chemical and biopharmaceutical industries. His biopharmaceutical experience comes from working for Bayer (now Grifols), in their plasma fractionation business unit, and Diosynth Biotechnology (now Fujifilm Diosynth Biotechnologies), a contract manufacturer of biopharmaceuticals. While at Diosynth, he led downstream process development and cGMP manufacturing groups. He was involved in the development and manufacture of more than 10 different protein therapeutics produced in a variety of host systems.
Dr. Gilleskie received his bachelor's degree in chemical engineering from NC State in 1986 and his doctorate in chemical engineering from the University of Minnesota in 1993.